The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biobanking Market Research Report 2024
Synopsis
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
The global Biobanking market was valued at US$ 2935 million in 2023 and is anticipated to reach US$ 4707.9 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Global Biobanking key players include Thermo Fisher, Beckman Coulter, Panasonic, etc. Global top three manufacturers hold a share over 15%.
United States is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 50 percent.
In terms of product, Consumable is the largest segment, with a share about 55%. And in terms of application, the largest application is Population Biobanks, followed by Tissue Biobanks, Virtual Biobanks, etc.
This report aims to provide a comprehensive presentation of the global market for Biobanking, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biobanking.
Report Scope
The Biobanking market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biobanking market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biobanking companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
Segment by Type
Equipment
Consumable
Segment by Application
Virtual Biobanks
Tissue Biobanks
Population Biobanks
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biobanking companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
The global Biobanking market was valued at US$ 2935 million in 2023 and is anticipated to reach US$ 4707.9 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Global Biobanking key players include Thermo Fisher, Beckman Coulter, Panasonic, etc. Global top three manufacturers hold a share over 15%.
United States is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 50 percent.
In terms of product, Consumable is the largest segment, with a share about 55%. And in terms of application, the largest application is Population Biobanks, followed by Tissue Biobanks, Virtual Biobanks, etc.
This report aims to provide a comprehensive presentation of the global market for Biobanking, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biobanking.
Report Scope
The Biobanking market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biobanking market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biobanking companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
Segment by Type
Equipment
Consumable
Segment by Application
Virtual Biobanks
Tissue Biobanks
Population Biobanks
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biobanking companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biobanking Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Equipment
1.2.3 Consumable
1.3 Market by Application
1.3.1 Global Biobanking Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Virtual Biobanks
1.3.3 Tissue Biobanks
1.3.4 Population Biobanks
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biobanking Market Perspective (2019-2030)
2.2 Biobanking Growth Trends by Region
2.2.1 Global Biobanking Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biobanking Historic Market Size by Region (2019-2024)
2.2.3 Biobanking Forecasted Market Size by Region (2025-2030)
2.3 Biobanking Market Dynamics
2.3.1 Biobanking Industry Trends
2.3.2 Biobanking Market Drivers
2.3.3 Biobanking Market Challenges
2.3.4 Biobanking Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biobanking Players by Revenue
3.1.1 Global Top Biobanking Players by Revenue (2019-2024)
3.1.2 Global Biobanking Revenue Market Share by Players (2019-2024)
3.2 Global Biobanking Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biobanking Revenue
3.4 Global Biobanking Market Concentration Ratio
3.4.1 Global Biobanking Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biobanking Revenue in 2023
3.5 Biobanking Key Players Head office and Area Served
3.6 Key Players Biobanking Product Solution and Service
3.7 Date of Enter into Biobanking Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biobanking Breakdown Data by Type
4.1 Global Biobanking Historic Market Size by Type (2019-2024)
4.2 Global Biobanking Forecasted Market Size by Type (2025-2030)
5 Biobanking Breakdown Data by Application
5.1 Global Biobanking Historic Market Size by Application (2019-2024)
5.2 Global Biobanking Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biobanking Market Size (2019-2030)
6.2 North America Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biobanking Market Size by Country (2019-2024)
6.4 North America Biobanking Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biobanking Market Size (2019-2030)
7.2 Europe Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biobanking Market Size by Country (2019-2024)
7.4 Europe Biobanking Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biobanking Market Size (2019-2030)
8.2 Asia-Pacific Biobanking Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biobanking Market Size by Region (2019-2024)
8.4 Asia-Pacific Biobanking Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biobanking Market Size (2019-2030)
9.2 Latin America Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biobanking Market Size by Country (2019-2024)
9.4 Latin America Biobanking Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biobanking Market Size (2019-2030)
10.2 Middle East & Africa Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biobanking Market Size by Country (2019-2024)
10.4 Middle East & Africa Biobanking Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Biobanking Introduction
11.1.4 Thermo Fisher Revenue in Biobanking Business (2019-2024)
11.1.5 Thermo Fisher Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Biobanking Introduction
11.2.4 Beckman Coulter Revenue in Biobanking Business (2019-2024)
11.2.5 Beckman Coulter Recent Development
11.3 Panasonic
11.3.1 Panasonic Company Detail
11.3.2 Panasonic Business Overview
11.3.3 Panasonic Biobanking Introduction
11.3.4 Panasonic Revenue in Biobanking Business (2019-2024)
11.3.5 Panasonic Recent Development
11.4 SOL Group
11.4.1 SOL Group Company Detail
11.4.2 SOL Group Business Overview
11.4.3 SOL Group Biobanking Introduction
11.4.4 SOL Group Revenue in Biobanking Business (2019-2024)
11.4.5 SOL Group Recent Development
11.5 Promega
11.5.1 Promega Company Detail
11.5.2 Promega Business Overview
11.5.3 Promega Biobanking Introduction
11.5.4 Promega Revenue in Biobanking Business (2019-2024)
11.5.5 Promega Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Biobanking Introduction
11.6.4 Merck Revenue in Biobanking Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Greiner Bio One
11.7.1 Greiner Bio One Company Detail
11.7.2 Greiner Bio One Business Overview
11.7.3 Greiner Bio One Biobanking Introduction
11.7.4 Greiner Bio One Revenue in Biobanking Business (2019-2024)
11.7.5 Greiner Bio One Recent Development
11.8 Chart Industries
11.8.1 Chart Industries Company Detail
11.8.2 Chart Industries Business Overview
11.8.3 Chart Industries Biobanking Introduction
11.8.4 Chart Industries Revenue in Biobanking Business (2019-2024)
11.8.5 Chart Industries Recent Development
11.9 Brooks Life Science
11.9.1 Brooks Life Science Company Detail
11.9.2 Brooks Life Science Business Overview
11.9.3 Brooks Life Science Biobanking Introduction
11.9.4 Brooks Life Science Revenue in Biobanking Business (2019-2024)
11.9.5 Brooks Life Science Recent Development
11.10 Tecan Group
11.10.1 Tecan Group Company Detail
11.10.2 Tecan Group Business Overview
11.10.3 Tecan Group Biobanking Introduction
11.10.4 Tecan Group Revenue in Biobanking Business (2019-2024)
11.10.5 Tecan Group Recent Development
11.11 QIAGEN
11.11.1 QIAGEN Company Detail
11.11.2 QIAGEN Business Overview
11.11.3 QIAGEN Biobanking Introduction
11.11.4 QIAGEN Revenue in Biobanking Business (2019-2024)
11.11.5 QIAGEN Recent Development
11.12 BD
11.12.1 BD Company Detail
11.12.2 BD Business Overview
11.12.3 BD Biobanking Introduction
11.12.4 BD Revenue in Biobanking Business (2019-2024)
11.12.5 BD Recent Development
11.13 Lifeline Scientific
11.13.1 Lifeline Scientific Company Detail
11.13.2 Lifeline Scientific Business Overview
11.13.3 Lifeline Scientific Biobanking Introduction
11.13.4 Lifeline Scientific Revenue in Biobanking Business (2019-2024)
11.13.5 Lifeline Scientific Recent Development
11.14 Hamilton
11.14.1 Hamilton Company Detail
11.14.2 Hamilton Business Overview
11.14.3 Hamilton Biobanking Introduction
11.14.4 Hamilton Revenue in Biobanking Business (2019-2024)
11.14.5 Hamilton Recent Development
11.15 So-Low
11.15.1 So-Low Company Detail
11.15.2 So-Low Business Overview
11.15.3 So-Low Biobanking Introduction
11.15.4 So-Low Revenue in Biobanking Business (2019-2024)
11.15.5 So-Low Recent Development
11.16 TTP Labtech Ltd
11.16.1 TTP Labtech Ltd Company Detail
11.16.2 TTP Labtech Ltd Business Overview
11.16.3 TTP Labtech Ltd Biobanking Introduction
11.16.4 TTP Labtech Ltd Revenue in Biobanking Business (2019-2024)
11.16.5 TTP Labtech Ltd Recent Development
11.17 Biolife Solutions
11.17.1 Biolife Solutions Company Detail
11.17.2 Biolife Solutions Business Overview
11.17.3 Biolife Solutions Biobanking Introduction
11.17.4 Biolife Solutions Revenue in Biobanking Business (2019-2024)
11.17.5 Biolife Solutions Recent Development
11.18 DNA Genotek
11.18.1 DNA Genotek Company Detail
11.18.2 DNA Genotek Business Overview
11.18.3 DNA Genotek Biobanking Introduction
11.18.4 DNA Genotek Revenue in Biobanking Business (2019-2024)
11.18.5 DNA Genotek Recent Development
11.19 Custom Biogenic Systems
11.19.1 Custom Biogenic Systems Company Detail
11.19.2 Custom Biogenic Systems Business Overview
11.19.3 Custom Biogenic Systems Biobanking Introduction
11.19.4 Custom Biogenic Systems Revenue in Biobanking Business (2019-2024)
11.19.5 Custom Biogenic Systems Recent Development
11.20 LVL Technologies
11.20.1 LVL Technologies Company Detail
11.20.2 LVL Technologies Business Overview
11.20.3 LVL Technologies Biobanking Introduction
11.20.4 LVL Technologies Revenue in Biobanking Business (2019-2024)
11.20.5 LVL Technologies Recent Development
11.21 BioRep
11.21.1 BioRep Company Detail
11.21.2 BioRep Business Overview
11.21.3 BioRep Biobanking Introduction
11.21.4 BioRep Revenue in Biobanking Business (2019-2024)
11.21.5 BioRep Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
